SCHEMBL1933458

SCHEMBL1933458

CCCCNC1CCC(NCCCC)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GNAI3 P08754 2/20 0.57
▸ GNAO1 P09471 2/20 0.57
▸ GNAI1 P63096 2/20 0.57
▸ S1PR4 O95977 2/20 0.47
▸ S1PR1 P21453 2/20 0.47
▸ S1PR3 Q99500 2/20 0.47
▸ METAP1 P53582 1/20 0.41
▸ DRD2 P14416 2/20 0.41
▸ DRD3 P35462 2/20 0.41
▸ FUCA1 P04066 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ S1PR5 Q9H228 1/20 0.41
▸ CYP2C9 P11712 1/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.40
▸ SPHK1 Q9NYA1 1/20 0.40
▸ CNR1 P21554 2/20 0.40
▸ CNR2 P34972 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ GBA1 P04062 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1678660 1.00 — —
SCHEMBL21089248 0.93 GNAI3 (0.52) GNAI3GNAO1GNAI1S1PR4S1PR1
SCHEMBL530708 0.92 — —
SCHEMBL13999315 0.91 GNAI3 (0.50) GNAI3GNAO1GNAI1S1PR4S1PR1
SCHEMBL24210534 0.90 GNAI3 (0.70) GNAI3GNAO1GNAI1S1PR4S1PR1
SCHEMBL20746945 0.90 GNAI3 (0.70) GNAI3GNAO1GNAI1S1PR4S1PR1
SCHEMBL1485880 0.90 GNAI3 (0.53) GNAI3GNAO1GNAI1S1PR4S1PR1
SCHEMBL194145 0.90 — —
SCHEMBL9155873 0.90 GNAI3 (0.70) GNAI3GNAO1GNAI1S1PR4S1PR1
SCHEMBL31020849 0.90 GNAI3 (0.70) GNAI3GNAO1GNAI1S1PR4S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624265-B2 Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof ADEKA CORPORATION (JP) 2026-05-12 — — US disclosed
US-20250163281-A1 THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME ADEKA CORPORATION (JP) 2025-05-22 — — US disclosed
EP-4484465-A1 THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME ADEKA CORPORATION (JP) 2025-01-01 — — EP disclosed
CN-118749016-A Thermoplastic resin composition for hot melt lamination molding, molded body, and method for producing the same 株式会社ADEKA 2024-10-08 — — CN disclosed
WO-2023163017-A1 THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME 株式会社ADEKA 2023-08-31 — — WO disclosed
EP-3945102-B1 ANTISTATIC AGENT, ANTISTATIC COMPOSITION COMPRISING SAME, ANTISTATIC RESIN COMPOSITION COMPRISING SAME, AND MOLDED ARTICLE THEREOF ADEKA CORP (JP) 2023-08-02 — — EP disclosed
WO-2023281602-A1 THERMOPLASTIC RESIN COMPOSITION, MOLDED ARTICLE AND PRODUCT 三菱電機株式会社 2023-01-12 — — WO disclosed
US-20220177757-A1 ANTISTATIC AGENT, ANTISTATIC COMPOSITION COMPRISING SAME, ANTISTATIC RESIN COMPOSITION COMPRISING SAME, AND MOLDED ARTICLE THEREOF ADEKA CORPORATION (JP) 2022-06-09 — — US disclosed
EP-3945102-A1 ANTISTATIC AGENT, ANTISTATIC COMPOSITION COMPRISING SAME, ANTISTATIC RESIN COMPOSITION COMPRISING SAME, AND MOLDED ARTICLE THEREOF ADEKA CORPORATION (JP) 2022-02-02 — — EP disclosed
EP-3196273-B1 ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE ADEKA CORP (JP) 2021-06-30 — — EP disclosed
US-9580545-B2 Antistatic agent, antistatic agent composition, antistatic resin composition, and molded article ADEKA CORPORATION (JP) 2017-02-28 — — US disclosed
US-20160289375-A1 ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE ADEKA CORPORATION (JP) 2016-10-06 — — US disclosed
EP-2977424-A1 ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE Adeka Corporation (JP) 2016-01-27 — — EP disclosed
EP-2949721-A1 ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED BODY Adeka Corporation (JP) 2015-12-02 — — EP disclosed
US-8080626-B2 Chain extenders ALBEMARLE CORPORATION (US) 2011-12-20 — — US disclosed
US-7964695-B2 Chain extenders ALBEMARLE CORPORATION (US) 2011-06-21 — — US disclosed
US-20110137005-A1 Chain Extenders ALBEMARLE CORPORATION (US) 2011-06-09 — — US disclosed
EP-2078048-A1 DIAMINE CHAIN EXTENDER COMPOSITIONS Albemarle Corporation (US) 2009-07-15 — — EP disclosed
WO-2008039571-A1 DIAMINE CHAIN EXTENDER COMPOSITIONS ALBEMARLE CORPORATION (US) 2008-04-03 — — WO disclosed
US-20070270566-A1 Chain Extenders ALBEMARLE CORPORATION (US) 2007-11-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270566-A1 Chain Extenders DDC, PARG, ODC1 GNAI3 3803/4885GNAO1 4338/4885GNAI1 4112/4885
US-12624265-B2 Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof SORD, SUCLA2, SUCLG1 GNAI3 4879/4885GNAO1 4587/4885GNAI1 4860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback